Biologically Active Small Molecules

A theoretical product of adrenic acid in the COX pathway primarily produced in renal medulla where adrenic acid is selectively distributed.

A process-related impurity commonly found in the bulk synthesis of candesartan cilexetil.

A process-related impurity commonly found in the bulk synthesis of candesartan cilexetil.

A process-related impurity commonly found in the bulk synthesis of candesartan cilexetil.

A prodrug form of 5-azacytidine, an inhibitor of DNA methyltransferaes, that may reverse epigenetic changes.

A prodrug form of 5-azacytidine, an inhibitor of DNA methyltransferaes, that may reverse epigenetic changes.

A prodrug form of 5-azacytidine, an inhibitor of DNA methyltransferaes, that may reverse epigenetic changes.

A prodrug form of 5-azacytidine, an inhibitor of DNA methyltransferaes, that may reverse epigenetic changes.

An in vitro inhibitor of reverse transcriptases from retroviruses, including HIV-1 and visna (Kis = 20 and 37 nM, respectively) also blocks, in vitro, mammalian and bacterial DNA polymerases.

A derivative of AMP that has been used in the synthesis of novel photoaffinity labels for incorporation into DNA and to study adenosine-based interactions during DNA synthesis and DNA damage.

A derivative of AMP that has been used in the synthesis of novel photoaffinity labels for incorporation into DNA and to study adenosine-based interactions during DNA synthesis and DNA damage.

A derivative of AMP that has been used in the synthesis of novel photoaffinity labels for incorporation into DNA and to study adenosine-based interactions during DNA synthesis and DNA damage.